The COVID-19 diagnostic tests were brought into the market after sustained clinical studies were conducted on biological samples from patients in Romania.
Parallel tests were performed, from the same biological sample, using the RT-PCR method and by chemiluminiscence methods, on analysers, in clinical laboratories. The results correlation and the statistical calculations showed excellent analytical performances of the quick tests, with a low detection limit, and with high accuracy.
COVID-19 diagnostic tests:
- rapid test to determine the COVID-19 Antigen – result in 15 minutes
- rapid test to determine the COVID-19 IgG and IgM Antibodies – result in 10 minutes
- tests very easy to use, full kit
- for professional use (also suited for personal use)
- made and checked in Romania
- officially approved and registered with ANMDMR, with CE marking
Rapid tests offer speed, reliability and quick responses to isolate COVID cases, which is still crucial to slow down the spread of the pandemic. Testing remains a key pillar in controlling and mitigating the ongoing COVID-19 pandemic, even after rolling out the COVID vaccines. Scaling up the testing capacity using rapid diagnostic kits in parallel with the vaccination is meant to keep the virus under control.
For further information and details you can send a message to the e-mail address email@example.com.
IASP assumes no responsibility or liability for the solutions shared on this site or the results obtained from their use. The information contained in this site is provided on an "as is" basis with no guarantee of completeness, accuracy, timeliness or of the results obtained from the use of this information.